Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq:WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024, at 3:00 p.m. PT / 6:00 p.m. ET.
Related news for (WVE)
- Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA’s Annual Scientific Sessions
- Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
- Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
- Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
- Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update